Cephalon were obvously informed of the results of the phase iia trial before the bid. This way they still had time to promote their 'huge premium' case.
Arana's new CEO hasn't even bothered to respond to the market but the special dividend says he also approves of this very low offer (which is not special at all because it is being deducted from the offer).
At least the offer has established a rock bottom valuation for the company.
- Forums
- ASX - By Stock
- AAH
- offer
AAH
arana therapeutics limited
offer, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
VMM
VIRIDIS MINING AND MINERALS LIMITED
Rafael Moreno, CEO
Rafael Moreno
CEO
SPONSORED BY The Market Online